Robert Sidonio on the Role of aPCC in Patients Receiving Emicizumab Prophylaxis
Robert Sidonio, Professor of Pediatrics at Emory University Hospital, shared a post on LinkedIn:
”It is our great pleasure to share that our publication “Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice” is now available for free access online as Pre-proof. Thanks to Takeda for organizing this awesome group of hematologists!”
Read the full article here.
In the recently published article ‘Activated Prothrombin Complex Concentrate in Patients Receiving Emicizumab Prophylaxis: From Evidence to Clinical Practice‘ by Robert F. Sidonio Jr. et al., in the RPTH Journal, the role of Activated Prothrombin Complex Concentrate in patients receiving Emicizumab prophyaxis is discussed.
Stay updated on the latest scientific advancements in the filed with Hemostasis Today.
-
Nov 16, 2025, 19:46Ayodeji Olayanju: Academics Blood Matter Too!
-
Nov 16, 2025, 19:30Thomas Reiser Congratulates Saskia Middeldorp on Delivering the 2025 Sol Sherry Distinguished Lecture in Thrombosis
-
Nov 15, 2025, 15:47Shannon Farmer: Congratulations to Susan Goobie and Colleagues on Publication of Their Important Study
-
Nov 15, 2025, 15:46Fotios Barkas: Explore the Latest Articles From the Journal of Atherosclerosis Prevention and Treatment!
-
Nov 15, 2025, 15:45Ludovic Helfgott: Researchers Have Analysed Novo Nordisk Product Data in Obesity and Cardiovascular Disease
-
Nov 15, 2025, 15:42Haroun Gajraj Thanks Enric Roche for Demonstrating the Piston Effect
-
Nov 15, 2025, 15:41Thrombectomy Rates Rise 700% Nationwide
-
Nov 15, 2025, 15:41Emmanuel J. Favaloro: Transitioning Patients from DOACs to Heparin
-
Nov 15, 2025, 15:40Bruno Lima: I Owe a Lot of My Career to Dr. Brad Maron